Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | ATM |
Variant | S2017fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | ATM S2017fs results in a change in the amino acid sequence of the Atm protein beginning at aa 2017of 3056, likely resulting in premature truncation of the functional protein (UniProt.org). Due to the loss of most known functional domains (UniProt.org), S2017f is predicted to lead to a loss of Atm protein function. |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM inact mut ATM S2017fs |
Transcript | NM_000051.3 |
gDNA | chr11:g.(108315864_108315865) |
cDNA | c.(6049_6048) |
Protein | p.S2017fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005271561 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017789 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_011542840 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_006718843 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
NM_000051 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017790 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017791 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_005271562 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_011542843 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_011542843.2 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
XM_017017791.1 | chr11:g.(108315864_108315865) | c.(6049_6048) | p.S2017fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|